PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42 | +55.6% | 13,316 | +120.0% | 0.00% | – |
| Q2 2023 | $27 | -54.2% | 6,052 | -41.4% | 0.00% | – |
| Q1 2023 | $59 | -89.3% | 10,322 | -88.6% | 0.00% | – |
| Q4 2022 | $549 | -98.4% | 90,824 | +1657.4% | 0.00% | – |
| Q3 2022 | $34,000 | +61.9% | 5,168 | +27.3% | 0.00% | – |
| Q2 2022 | $21,000 | -47.5% | 4,060 | -30.9% | 0.00% | – |
| Q1 2022 | $40,000 | – | 5,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $124,994,000 | 1.61% |
| Baker Brothers Advisors | 10,123,824 | $126,042,000 | 0.61% |
| Pinz Capital Management, LP | 43,800 | $545,000 | 0.21% |
| HHLR ADVISORS, LTD. | 583,333 | $7,262,000 | 0.11% |
| Rock Springs Capital Management LP | 368,959 | $4,594,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 20,350 | $253,000 | 0.08% |
| Virtus ETF Advisers LLC | 13,815 | $172,000 | 0.06% |
| PDT Partners, LLC | 35,907 | $447,000 | 0.03% |
| Jump Financial, LLC | 36,900 | $459,000 | 0.03% |
| Parkwood LLC | 12,667 | $158,000 | 0.03% |